NEUP vs. WGRX

Last updated Apr 2, 2026

Compare and contrast key facts about Neuphoria Therapeutics Inc (NEUP) and Wellgistics Health, Inc (WGRX).

Performance

NEUP vs. WGRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neuphoria Therapeutics Inc (NEUP) and Wellgistics Health, Inc (WGRX). The values are adjusted to include any dividend payments, if applicable.

NEUP vs. WGRX - Yearly Performance Comparison

	2026 (YTD)	2025
NEUP Neuphoria Therapeutics Inc	6.19%	-20.49%
WGRX Wellgistics Health, Inc	-73.22%	-89.51%

Fundamentals

Market Cap NEUP : $18.69M WGRX : $7.60M
EPS NEUP : -$133.25 WGRX : -$1.47
PS Ratio NEUP : 1.41 WGRX : 0.32
Total Revenue (TTM) NEUP : $8.21M WGRX : $23.34M
Gross Profit (TTM) NEUP : $8.03M WGRX : -$6.43M
EBITDA (TTM) NEUP : -$847.60M WGRX : -$90.54M

Returns By Period

In the year-to-date period, NEUP achieves a 6.19% return, which is significantly higher than WGRX's -73.22% return.

NEUP

• 1D: 1.23%
• 1M: -3.29%
• YTD: 6.19%
• 6M: -70.25%
• 1Y: -27.72%
• 3Y*: —
• 5Y*: —
• 10Y*: —

WGRX

• 1D: 11.00%
• 1M: -54.00%
• YTD: -73.22%
• 6M: -87.33%
• 1Y: -97.66%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NEUP vs. WGRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEUP

NEUP Risk / Return Rank: 38
NEUP Sharpe Ratio Rank: 30
NEUP Sortino Ratio Rank: 47
NEUP Omega Ratio Rank: 54
NEUP Calmar Ratio Rank: 29
NEUP Martin Ratio Rank: 31

WGRX

WGRX Risk / Return Rank: 10
WGRX Sharpe Ratio Rank: 23
WGRX Sortino Ratio Rank: 4
WGRX Omega Ratio Rank: 8
WGRX Calmar Ratio Rank: 1
WGRX Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEUP vs. WGRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neuphoria Therapeutics Inc (NEUP) and Wellgistics Health, Inc (WGRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NEUP	WGRX	Difference
Sharpe ratio Return per unit of total volatility	-0.22	-0.40	+0.18
Sortino ratio Return per unit of downside risk	0.74	-1.58	+2.33
Omega ratio Gain probability vs. loss probability	1.14	0.84	+0.30
Calmar ratio Return relative to maximum drawdown	-0.35	-1.00	+0.65
Martin ratio Return relative to average drawdown	-0.53	-1.24	+0.71
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NEUP vs. WGRX - Sharpe Ratio Comparison

The current NEUP Sharpe Ratio is -0.22, which is higher than the WGRX Sharpe Ratio of -0.40. The chart below compares the historical Sharpe Ratios of NEUP and WGRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NEUP	WGRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.22	-0.40	+0.18
Sharpe Ratio (All Time) Calculated using the full available price history	-0.45	-0.40	-0.05

Correlation

The correlation between NEUP and WGRX is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NEUP vs. WGRX - Dividend Comparison

Neither NEUP nor WGRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

NEUP vs. WGRX - Drawdown Comparison

The maximum NEUP drawdown since its inception was -96.32%, roughly equal to the maximum WGRX drawdown of -98.06%. Use the drawdown chart below to compare losses from any high point for NEUP and WGRX.

Drawdown Indicators

	NEUP	WGRX	Difference
Max Drawdown Largest peak-to-trough decline	-96.32%	-98.06%	+1.74%
Max Drawdown (1Y) Largest decline over 1 year	-81.40%	-97.89%	+16.49%
Current Drawdown Current decline from peak	-94.82%	-97.84%	+3.02%
Average Drawdown Average peak-to-trough decline	-91.69%	-71.28%	-20.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	53.23%	78.62%	-25.39%

Volatility

NEUP vs. WGRX - Volatility Comparison

The current volatility for Neuphoria Therapeutics Inc (NEUP) is 15.30%, while Wellgistics Health, Inc (WGRX) has a volatility of 39.45%. This indicates that NEUP experiences smaller price fluctuations and is considered to be less risky than WGRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NEUP	WGRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.30%	39.45%	-24.15%
Volatility (6M) Calculated over the trailing 6-month period	138.87%	138.56%	+0.31%
Volatility (1Y) Calculated over the trailing 1-year period	125.70%	246.29%	-120.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	182.22%	239.80%	-57.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	182.22%	239.80%	-57.58%

Financials